Enhancement by peptide histidine isoleucine of experimental carcinogenesis in the colon of rats induced by azoxymethane. 1995

H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
Department of Gastrointestinal Oncology, Center for Adult Diseases, Osaka, Japan.

The effects of peptide histidine isoleucine (PHI) on the incidence and histology of colon tumors induced by azoxymethane (AOM), and on the labeling index of colon mucosa were investigated in Wistar rats. Rats received weekly s.c. injections of 7.4 mg/kg body weight of AOM for 10 weeks, and of 1.0 or 4.0 nmol/kg body weight of PHI until the end of the experiment in week 35. Administration of PHI at the higher, but not the lower dosage, significantly increased the incidence of colon tumors. PHI had no influence on the histology of colon tumors or adenocarcinomas. It also caused significant increase in the labeling index of colon epithelial cells. These findings indicate that PHI enhances colon carcinogenesis, and that its effect may be related to increasing proliferation of colon epithelial cells.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D010451 Peptide PHI A 27-amino acid peptide with histidine at the N-terminal and isoleucine amide at the C-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory, and central nervous systems. Neuropeptide PHI 27,PHI Peptide,Peptide Histidine-Isoleucine,Peptide PHM,Human PHI,PHM Neuropeptide,PHM-27,Peptide HI,Peptide Histidine Methionine,Peptide PHI-27,Peptide-Histidine-Isoleucinamide,Porcine Intestinal Heptacosapeptide,Pro-Vasoactive Intestinal Peptide,Heptacosapeptide, Porcine Intestinal,Histidine Methionine, Peptide,Histidine-Isoleucine, Peptide,Intestinal Heptacosapeptide, Porcine,Intestinal Peptide, Pro-Vasoactive,Methionine, Peptide Histidine,Neuropeptide, PHM,PHI, Human,PHM, Peptide,Peptide Histidine Isoleucinamide,Peptide Histidine Isoleucine,Peptide PHI 27,Peptide, PHI,Peptide, Pro-Vasoactive Intestinal,Pro Vasoactive Intestinal Peptide
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005755 Gastrins A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters. Gastrin
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001397 Azoxymethane A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas.

Related Publications

H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
September 1990, British journal of cancer,
H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
August 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
December 1997, The Journal of nutrition,
H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
July 1984, Journal of the National Cancer Institute,
H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
August 1994, Cancer letters,
H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
January 1983, Carcinogenesis,
H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
June 1993, Cancer research,
H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
June 2019, Cancer prevention research (Philadelphia, Pa.),
H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
June 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
H Iishi, and M Tatsuta, and M Baba, and K Iseki, and H Uehara, and A Nakaizumi
June 1991, Cancer research,
Copied contents to your clipboard!